SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-368134
Filing Date
2015-11-05
Accepted
2015-11-05 15:32:27
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d59453d10q.htm 10-Q 541587
2 EX-31.1 d59453dex311.htm EX-31.1 6682
3 EX-31.2 d59453dex312.htm EX-31.2 6705
4 EX-32.1 d59453dex321.htm EX-32.1 2867
5 EX-32.2 d59453dex322.htm EX-32.2 2963
  Complete submission text file 0001193125-15-368134.txt   3772124

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20150930.xml EX-101.INS 571326
7 XBRL TAXONOMY EXTENSION SCHEMA infi-20150930.xsd EX-101.SCH 55750
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE infi-20150930_cal.xml EX-101.CAL 66029
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE infi-20150930_def.xml EX-101.DEF 268640
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20150930_lab.xml EX-101.LAB 414177
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20150930_pre.xml EX-101.PRE 310099
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 151200319
SIC: 2834 Pharmaceutical Preparations